MarketScreener Editorial Features Adherex Technologies Inc. (USA) Other OTC
Equities
CA00686R4089
End-of-day quote
Other stock markets
|
||
- USD | - |
05-15 | HC Wainwright Adjusts Fennec Pharmaceuticals Price Target to $15 From $18, Maintains Buy Rating | MT |
05-14 | Transcript : Fennec Pharmaceuticals Inc., Q1 2024 Earnings Call, May 14, 2024 |
MarketScreener Editorial Features
Today on Wall Street: Back to the guessing game | November 29, 2021 at 11:28 am |
- Stock Market
- Equities
- FENC Stock
- Stock
- News Adherex Technologies Inc. (USA)
- MarketScreener Editorial Features